Market Share of Pain Medications in 2018 Nature Review
Postoperative Pain Management Market place Outlook (2022-2031)
The global market for postoperative pain direction was valued at United states$ 35.5 Bn in 2021. Market growth is predicted at v% CAGR to reach a valuation of United states of america$ 57.8 Bn past 2031.
| Postoperative Pain Management Market Size (2021) | US$ 35.5 Bn |
| Projected Market Value (2031) | US$ 57.viii Bn |
| Global Marketplace Growth Rate (2022-2031) | 5% CAGR |
| Market Share of Top 5 Countries | 67% |
The opioids segment is the nigh dominating (61.9% share) owing to comparatively higher costs leading to more revenue and ameliorate pain relief. In 2021, postoperative pain management deemed for approximately 52.half dozen% of the global pain management market.
Notice Out More well-nigh the Written report Coverage
Companies
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Allergan plc
- Mylan N.5
- Pfizer Inc.
- Purdue Pharma L.P
- Janssen Pharmaceuticals, Inc.
- Endo International plc
- Pacira Pharmaceuticals Inc.
- Egalet Corporation
- GlaxoSmithKline Plc.
Postoperative Hurting Management Demand Analysis (2016-2021) Vs Market Outlook (2022-2031)
Sales of postoperative pain direction drugs increased at a CAGR of four.vii% from 2016 to 2021.
Rising prevalence of chronic affliction, growing number of surgical procedures, increasing demand for novel not-opioid analgesics in postoperative pain management therapy, and elevating awareness about palliative care are surging need for postoperative pain treatment procedures.
Rising demand for pain management drugs is a driving factor for market growth. As per National Health statistics, 100 million surgeries takes place in the U.S. annually. Surging rate of surgeries across the globe is the main reason for the high consumption of pain management drugs. Similarly, increasing cancer therapy-associated pain incidence and growing pediatric and ageing population undergoing unlike types of surgeries are leading to the growth of the market.
Over the coming years, route accidents are expected to surge due to increasing number of vehicles. Also, many individuals do not follow road rules seriously. Rising cases of accidents on road, relative trauma injuries, and demand for hurting management post surgeries are expected to drive postoperative pain management demand in future.
These incidents causes immense pain to the patient if not treated immediately and effectively. However, postoperative pain direction is helpful to manage heavy pain and soreness. The availability of pain medications will be higher for such road accidents. The key players are increasing their production due to these factors which will ultimately lead to positive growth in the post-operative pain direction market.
Increasing focus of key players on the development of abuse-deterrent opioid drugs and introduction of extended-release non-opioid drugs for post-surgery pain management are surging demand for painkiller drugs. Similarly, rising sensation regarding post-surgery hurting command along with increased development and commercialization of not-narcotic drugs and not-abuse opioids is supplementing market growth.
Considering all these factors, Persistence Market place Enquiry expects the global postoperative pain management market to expand at a CAGR of 5% through 2031.
Customize this Report
Explore Intelligence Tailored to Your Business organization Goals.
What is the Outlook for the Postoperative Hurting Management Market?
"Market Players Can Look to Asia and MEA for Growth Opportunities"
Opioids are usually used for postoperative hurting management in Northward America and Europe, but due to increased use of opioids for non-medical purposes, governing bodies are encouraging doctors to prescribe non-opioid drugs, which gives companies the opportunity to introduce novel not-opioid drugs.
In North America and Europe, clinicians can choose not-opioid medicine formulations with innovative drug commitment systems over opioid drugs for postoperative hurting direction. While opioid and not-opioid drugs with innovative drug delivery systems are non generally accessible for postoperative hurting direction in Asia and Africa.
Due to the lack of efficient postoperative pain management medications, a big section of the population in Asia and Africa stays untreated, thereby creating potential for postoperative pain direction market players to grow in these regions.
Market Inquiry Methodology - Perfected through Years of Diligence
A cardinal factor for our unrivaled marketplace inquiry accuracy is our skilful- and data-driven research methodologies. Nosotros combine an eclectic mix of feel, analytics, auto learning, and data scientific discipline to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Are There Whatever Restraints for Post-op Pain Relief Market Expansion?
"Concerns Regarding Overuse of Opioids to Negatively Impact Marketplace Growth"
Growing concerns regarding the opioid epidemic and increasing price burden of pain management on reimbursement providers are factors expected to hamper market expansion of pain direction in postoperative patients to some extent.
Adverse side effects associated with excessive intake of NSAIDs and opioids and limited availability of postoperative pain management drugs are other factors hampering the market in Asia and Africa. For example, loftier consumption of morphine could upshot in astringent harm to the respiratory system, which can fifty-fifty result in coma and death. Long-term use of morphine can result in its psychological and physical addiction, and could substantially dent the body'south immune posture.
Increase in drug abuse incidence and the addictive nature of opioids have declined the employ of prescriptions for opioids in developed region. This has led to decrease in opioid consumption for pain management, which may further touch on market growth.
Explore Persistence Marketplace Research's expertise in promulgation of the business organisation !
State-wise Insights
What Makes the U.South. a Huge Marketplace for Postoperative Pain Management?
"Strong Postoperative Pain Direction Drug Pipeline in the U.Southward."
The U.S. is estimated to account for 87.ix% of the North America postoperative pain management market in 2022. Adoption of opioid management treatment is expected to reduce the growing prevalence of the opioid epidemic in N America, particularly in the U.S. For instance, in 2017, 191 million opioid drugs were prescribed and dispensed to patients in the U.S.
Furthermore, presence of a strong drug pipeline with constructive drugs coming up for approvals by the U.S. Food and Drug Administration is further expected to increment the use of postoperative pain management drugs in this region.
Which Country is a Lucrative Market for Hurting Direction in Postoperative Patients in Europe?
"Germany to Atomic number 82 Opioid Dependence Handling in Europe"
Federal republic of germany is expected to account for 26.9% of the European postoperative pain management market in 2022.
High incidence and severity of postoperative pain, introduction of promising drugs, increment in the number of surgical procedures, and high charge per unit of hurting management procedures in adult countries such as Frg take driven market place growth.
Increasing acceptance of Opioid Maintenance Treatment (OMT) for treating Opioid Dependence (OD) is a major factor propelling demand for postoperative pain management drugs across Germany.
What's Fueling Demand for Postoperative Hurting Management Medication in China?
"High Number of Surgeries Driving Demand in China"
The China postoperative hurting management market is projected to expand at 6.6% CAGR due to increasing number of surgeries in the land.
Numerous pain direction drugs manufacturers are undergoing distribution agreements, partnerships, and launching postoperative hurting direction medications in the Asia Pacific region, specially in China.
- For instance, on May 1, 2018, Grunenthal signed a distribution and license agreement with Mundipharma; this agreement immune Mundipharma to promote and distribute Grunenthal's tramal (tramadol) in China.
Category-wise Insights
Which Drug Grade Holds Maximum Sway in this Manufacture?
"Demand for Opioid Drugs to Proceed Gaining Traction"
By drug class, the opioids segment is anticipated to concord a high share of 61.3% in 2022, expanding at 4% CAGR during the forecast period.
As per NIH, adults suffering from moderate to severe hurting after surgery are generally treated with opioids. Thus, utilise of opioids is increasing over the last decade. Based on research studies and ongoing trials, opioid drugs are known to be effective for postoperative hurting handling and have exhibited the power to support patients in achieving their clinical goals.
Which Route of Assistants is the Well-nigh Pop?
"Oral Postoperative Pain Management Procedures Highly Sought-after"
In terms of route of administration, oral postoperative pain management is projected to account for 37.8% of the total market place share in 2022. The oral route of administration is a widely accepted and more convenient for patients, especially for the elder population, which leads to a higher market share in the postoperative pain management mural.
Impact of COVID-19 Crisis
The market place for postoperative pain direction was hampered by unfavorable changes in regulations and guidelines during COVID-19. Cancer patients were at college hazard of COVID-xix infection than good for you persons, according to major regulatory bodies throughout the world (such every bit the CDC, WHO, MHRA, TGA, and EMA).
As a consequence, screening, diagnostic tests, and surgical treatments in hospitals and cancer centers were severely limited or postponed. The postoperative pain management market was disrupted as a result of this. Most hospitals gave more than importance to COVID-19 treatment and care, and only emergency surgeries were taking place.
However, from the second half of 2021, the market place has progressively grown owing to an increase in the number of infusion appointments and ablation operations, amid other things, as a issue of efforts to clear backlogs and new cases, as well as completely reopen healthcare services.
Competitive Landscape
Leading suppliers of postoperative pain direction medicines are undertaking collaborations and acquisitions equally the main strategy with dissimilar pharmaceutical companies for the evolution of novel production lines of drugs for pain direction.
- For example, in May 2020, Assertio Therapeutics, Inc. was acquired by Zyla Life Sciences. This created a growing commercial pharmaceutical company to increase its production portfolio in the neurology, inflammation, and hurting products partitioning.
Postoperative Pain Management Market Study Scope
| Attribute | Details |
| Forecast Menstruation | 2022-2031 |
| Historical Information Available for | 2016-2021 |
| Market Analysis | U.s.$ Meg for Value |
| Central Countries Covered |
|
| Primal Marketplace Segments Covered |
|
| Central Companies Profiled |
|
| Report Coverage |
|
| Customization & Pricing | Available upon Request |
Postoperative Hurting Management Industry Survey by Category
Postoperative Pain Management Market past Drug Class:
- Opioids
- NSAIDs
- Local Anesthetic
- Acetaminophen
Postoperative Pain Management Market past Route of Administration:
- Injectable Postoperative Hurting Management
- Oral Postoperative Pain Management
- Topical Postoperative Pain Management
- Transdermal Postoperative Hurting Direction
- Others
Postoperative Hurting Management Marketplace by Distribution Aqueduct:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Clinics
- Others
Postoperative Hurting Direction Market by Region:
- North America Postoperative Pain Management Marketplace
- Latin America Postoperative Pain Direction Market
- Europe Postoperative Hurting Management Market
- East asia Postoperative Pain Management Market
- Southern asia Postoperative Pain Management Market
- Oceania Postoperative Pain Management Market
- The Centre E and Africa (MEA) Postoperative Pain Management Market
Media Release
- Opioids to Business relationship for Two-3rd Share in Postoperative Pain Management Market place through 2031: Persistence Market Research
douglasalationever.blogspot.com
Source: https://www.persistencemarketresearch.com/market-research/postoperative-pain-management-market.asp
0 Response to "Market Share of Pain Medications in 2018 Nature Review"
Post a Comment